Awani International
  • LIVE
  • Videos
  • US-China
  • BRICS-RT
  • ASEAN
  • West Asia
  • Shows
  • Podcast
  • BM
    EN
  • LIVE
  • Login
  • BM
    EN
  • LIVE
  • Login
Awani International
  • LIVE
  • Videos
  • US-China
  • BRICS-RT
  • ASEAN
  • West Asia
  • Shows
  • Podcast
Israel reopens Gaza's Rafah border crossing to Egypt, with limits
Iran examines diplomacy with US, hopes for results in coming days, official says
Germany closer to US than China despite recent tensions, foreign minister says
  • PRIVACY POLICY
  • TERMS OF USE
  • ADVERTISE WITH US
  • INVESTOR

Astro AWANI | Copyright © 2025 Measat Broadcast Network Systems Sdn Bhd 199201008561 (240064-A)

RNA

New strategy for personalised cancer treatment to be presented at Innovation Space: the science behind a new kind of oncology
New strategy for personalised cancer treatment to be presented at Innovation Space: the science behind a new kind of oncology
19/06/2025
Long COVID appears to be driven by ‘long infection’. Here’s what the science says
Long COVID appears to be driven by ‘long infection’. Here’s what the science says
01/12/2024
In a first, RNA is recovered from extinct Tasmanian tiger
In a first, RNA is recovered from extinct Tasmanian tiger
23/09/2023
Sinovac regimen gets strong boost from Pfizer, AstraZeneca or J&J COVID shots - Study
Sinovac regimen gets strong boost from Pfizer, AstraZeneca or J&J COVID shots - Study
25/01/2022
From COVID to cancer: High hopes for 'versatile' mRNA
From COVID to cancer: High hopes for 'versatile' mRNA
16/10/2021
EU Commission to end AstraZeneca and J&J vaccine contracts at expiry - Paper
EU Commission to end AstraZeneca and J&J vaccine contracts at expiry - Paper
14/04/2021
Pfizer to make other vaccines using technology behind its COVID-19 shot - WSJ
Pfizer to make other vaccines using technology behind its COVID-19 shot - WSJ
23/03/2021
Five hurdles in the global COVID-19 vaccine rollout
Five hurdles in the global COVID-19 vaccine rollout
14/01/2021
Stemirna COVID-19 vaccine candidate obtains clinical trial approval in China
Stemirna COVID-19 vaccine candidate obtains clinical trial approval in China
05/01/2021
Explainer: How the Moderna vaccine stacks up against Pfizer/BioNTech's
Explainer: How the Moderna vaccine stacks up against Pfizer/BioNTech's
19/12/2020
Pfizer ends COVID-19 trial with 95 pct efficacy, to seek emergency-use authorisation
Pfizer ends COVID-19 trial with 95 pct efficacy, to seek emergency-use authorisation
18/11/2020
Moderna says its vaccine is 94.5% effective in preventing COVID-19
Moderna says its vaccine is 94.5% effective in preventing COVID-19
16/11/2020
Next crop of COVID-19 vaccine developers take more traditional route
Next crop of COVID-19 vaccine developers take more traditional route
29/10/2020